Johnson & Johnson

Since 2002, Johnson & Johnson has partnered with EGPAF to reduce mother-to-child transmission in more than 10 countries in sub-Saharan Africa and Asia. Since its inception, this important partnership has contributed to reaching more than 2.5 million pregnant women with lifesaving testing, care and treatment services. Through J&J support, EGPAF also has carried out a myriad of activities to support capacity building, technical advocacy, information sharing, and documentation around the adoption and implementation of revised WHO guidelines across its country programs. The partnership also supports the provision of cutting-edge training and mentorship aimed at increasing the management and leadership skills of HIV healthcare managers.